Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 5WY0FWR2CF

Pharmacology

Action Mechanism of Action Reference
ANTISENSE INHIBITOR Ribonucleotide reductase small subunit mRNA antisense inhibitor PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Breast Neoplasms, Male 2 D018567 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 236391-66-5
ChEMBL CHEMBL4297763
FDA SRS 5WY0FWR2CF
PubChem 91865462